Proteome Sciences (LON:PRM) Share Price Crosses Below Two Hundred Day Moving Average – Should You Sell?

Proteome Sciences plc (LON:PRM)’s share price crossed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of GBX 1.68 and traded as low as GBX 1.24. Proteome Sciences shares last traded at GBX 1.24, with a volume of 50,059 shares.

Proteome Sciences Stock Down 14.5%

The business has a fifty day moving average of GBX 1.47 and a 200 day moving average of GBX 1.68. The firm has a market cap of £4.36 million, a P/E ratio of -1.73 and a beta of 0.16. The company has a quick ratio of 0.37, a current ratio of 0.12 and a debt-to-equity ratio of -161.07.

Proteome Sciences (LON:PRM) last issued its earnings results on Wednesday, September 16th. The company reported GBX (0.41) earnings per share (EPS) for the quarter. Proteome Sciences had a positive return on equity of 23.85% and a negative net margin of 61.46%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.